Cardiovascular Imaging

Hypertensive patients who had periventricular white matter abnormalities progress from one brain scan to the next showed a six-fold increased risk of mild cognitive impairment, researchers reported Jan. 4 in Hypertension.

Physicians were exposed to seven times the amount of radiation when they performed coronary angiography on morbidly obese patients compared to those with normal bodyweights, according to a single-center study published Jan. 2 in Circulation: Cardiovascular Interventions.

The calcium-channel blocker nicardipine can effectively reverse coronary slow flow (CSF)—“an under-recognized cause of chest pain”—according to the authors of a study published online Dec. 15 in the Journal of Invasive Cardiology.

Using coronary CT angiography to identify which patients with suspected coronary artery disease (CAD) really need invasive angiography can lower the overall cost of diagnostic testing without sacrificing safety, suggests a randomized trial published Dec. 12 in JACC: Cardiovascular Imaging.

Data presented at the 2018 EuroEcho-Imaging congress in Milan suggest breast cancer patients who take the common chemo drug trastuzumab might be able to mitigate their risk of heart damage by supplementing with carvedilol, a beta-blocker used predominantly by cardiac patients.

Showing patients and their primary care doctors pictorial representations of carotid plaque may prompt greater adherence to lifestyle and medication interventions, resulting in lower cardiovascular disease risk within one year, according to a study published Dec. 3 in The Lancet.

Fractional flow reserve (FFR) assessment before coronary artery bypass grafting (CABG) didn’t improve outcomes compared to angiography-guided surgery, Danish researchers reported Nov. 26 in the Journal of the American College of Cardiology.

CT analysis prior to percutaneous pulmonary valve implantation (PPVI) in patients with congenital heart disease (CHD) could help physicians detect which individuals are at the greatest risk for coronary artery compression during the procedure, according to research published ahead of print in the European Journal of Radiology.

There were no adverse events related to atherosclerotic cardiovascular disease during a median 3.7 years of follow-up for 101 patients with familial hypercholesterolemia (FH) but a coronary artery calcium (CAC) score of zero, according to a study published Nov. 14 in JACC: Cardiovascular Imaging.

The use of intravascular ultrasound (IVUS) to guide PCI leads to further improvements in event-free survival between one and two years post-procedure, according to a report from the ADAPT-DES study published in Circulation: Cardiovascular Interventions.

As 3D printing continues to gain traction as a medical treatment tool, cardiologists across the globe are implementing the technology in their own departments and practices. But as they do, one radiologist cautions, it’s important they consider some critical groundwork that’s yet to be laid.

The shortage of Molybdenum-99 (Mo-99), which is used to create the crucial nuclear imaging radioisotope Technetium-99m, is expected to improve in the coming weeks.